TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Mar 20, 2025
MALVERN, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read more at globenewswire.comNASDAQ:TELA (8/1/2025, 4:30:01 PM)
1.86
+0.16 (+9.41%)
Find more stocks in the Stock Screener
